The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 92.50
High: 0.00
Low: 0.00
Prev. Close: 92.50
KAKU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

12 Mar 2010 07:00

RNS Number : 4890I
Kakuzi Ld
12 March 2010
 
KAKUZI LIMITED
 
ANNOUNCEMENT OF GROUP RESULTS FOR THE YEAR ENDED 31 DECEMBER 2009
 
 
 
2009
 
2008
 
 
 
Shs’000
 
Shs’000
 
 
 
 
 
 
 
Sales
 
2,008,157
 
1,613,216
 
Operating profit
 
578,363
 
441,588
 
Finance costs
 
(19,473
)
(51,399
)
Profit before income tax
 
558,890
 
390,189
 
Income tax expense
 
(168,595
)
(107,271
)
 
 
 
 
 
 
Profit for the year
 
390,295
 
282,918
 
 
 
 
 
 
 
Other comprehensive income
 
-
 
-
 
 
 
 
 
 
 
Total comprehensive income
 
390,295
 
282,918
 
 
 
 
 
 
 
Profit attributable to:
 
 
 
 
 
Equity holders of the company
 
339,897
 
257,188
 
Minority interest
 
50,398
 
25,730
 
 
 
 
 
 
 
Total comprehensive income attributable to:
 
 
 
 
 
Equity holders of the company
 
339,897
 
257,188
 
Minority interest
 
50,398
 
25,730
 
 
 
 
 
 
 
 
 
Shs
 
Shs
 
Earnings per share attributable to equity holders of company:
 
 
 
 
 
Basic and diluted earnings per stock unit
 
17.34
 
13.12
 
 
 
 
 
 
 
 
 
Shs’000
 
Shs’000
 
Dividends: -
 
 
 
 
 
Proposed first and final dividend for the year
 
49,000
 
19,600
 
 
 
 
 
 
 
NOTES
The above results are extracted from financial statements audited by PricewaterhouseCoopers, Certified Public Accountants of Kenya, and on which an unqualified opinion has been given.
 
Biological assets are measured at fair value less estimated point-of-sale costs in accordance with IAS 41, Agriculture. Included in the operating profit for 2009 is a contribution of Sh 64 million (2008: Sh 181 million) arising from the changes in the fair value less estimated point-of-sale costs for biological assets.
 
The principal contributions to operating profit in 2009 were derived from avocado and tea. 
 
DIVIDEND
The directors recommend the payment of a first and final dividend for the financial year 2009 of 50% equivalent to Shs 2.50 per stock unit (2008: Shs 1.00)
 
Subject to the shareholders approval, the Register of Members will be closed on Monday 31st May 2010 for the purpose of processing the dividend.
 
ANNUAL GENERAL MEETING
The Annual General Meeting of the company will be held on Thursday 27th May 2010 at 12.00 noon at Fairmont The Norfolk Hotel, Nairobi.
 
BY ORDER OF THE BOARD
 
MR K W TARPLEE
CHAIRMAN
11 MARCH 2010
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SFASIEFSSEID
12
Date   Source Headline
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
18th Mar 20117:39 amRNSFinal Results 2010
26th Jan 20117:00 amRNSPublic Announcement
25th Aug 20104:55 pmRNSHalf Yearly Report
12th Mar 20107:00 amRNSFinal Results
26th Aug 20097:00 amRNSHalf Yearly Report
5th Mar 20094:21 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.